Accolade (ACCD) Osake Kurssi
Accolade Kurssi
Viimeisten 6 vuoden aikana Accoladen liikevaihto kasvoi 33,2 % vuodessa ja ylsi 408,34 M USD:een. Accoladen nettomarginaali −24,4 % on noussut verrattuna −39,6 %:iin muutama vuosi sitten. Accoladen 12 kuukauden konsensustavoitehinta on 7,17 USD, noin yli kurssia 2,1 %. 18 analyytikosta 7 suosittaa ostoa — kokonaiskonsensus on Pidä.
Accolade osakekurssi
Accolade liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Accolade -osakkeesta
Accolade Inc operates as a healthcare technology and services company. The company's business model is based on providing personalized health and benefits solutions to individuals and their families. Accolade's services include healthcare navigation, behavioral health support, benefits advisory, and chronic condition management. By combining technology and human touch, Accolade aims to simplify and improve access to healthcare for its clients. Through their platform, Accolade Inc aims to empower individuals in making informed healthcare decisions, managing their health conditions, and optimizing their overall well-being. Accolade Inc strives to enhance healthcare outcomes and reduce costs for both individuals and employers.
Accolade Inc is primarily active in the healthcare and technology industries.
Accolade Inc faces competition from various companies in the market. Some of its main competitors include Teladoc Health, Livongo Health, and Health Catalyst. These companies also operate in the healthcare technology sector, providing similar services and solutions. However, Accolade Inc distinguishes itself through its unique combination of personal health support and advanced technology platforms, offering a comprehensive approach to healthcare management and improving patient outcomes.
Accolade Inc, founded in 2007, is a leading technology-enabled healthcare company headquartered in Seattle, Washington. The company provides personalized healthcare and benefits solutions to its clients, including employers, health plans, and health systems. With a mission to improve the healthcare experience for individuals and their families, Accolade Inc combines cutting-edge technology and human expertise to deliver personalized health and benefits services. Over the years, Accolade Inc has established itself as a trusted partner in the industry, leveraging their deep domain knowledge and innovative solutions to support individuals in navigating the complex healthcare landscape efficiently and effectively. This commitment to customer-centric healthcare has propelled Accolade Inc to become a recognized leader in the industry.
Accolade Inc has achieved several significant milestones since its inception. The company successfully completed its initial public offering (IPO) in July 2020, marking a major achievement in its growth trajectory. In recent years, Accolade Inc has formed strategic partnerships with various renowned healthcare organizations, enhancing its market presence and enabling provision of personalized healthcare solutions. With its innovative technology and dedicated team, Accolade Inc has rapidly expanded its customer base, serving millions of individuals across the United States. The company's revolutionary approach to healthcare management has garnered recognition, including being named a Fast Company's Most Innovative Company in 2021. Accolade Inc continues to drive innovation in the healthcare industry, revolutionizing the way individuals access and navigate their healthcare choices.
Accolade Inc is primarily present in the United States of America.
Accolade Inc represents values of innovation, collaboration, and customer-centricity. With a strong corporate philosophy focused on improving healthcare experiences, Accolade Inc strives to empower individuals and families to navigate their health and benefits in a personalized and effective manner. By combining technology and human expertise, the company aims to deliver comprehensive support, enhance outcomes, and reduce healthcare costs. Accolade Inc's commitment to delivering exceptional service and its emphasis on providing personalized health advocacy aligns with its mission to empower individuals and transform the healthcare industry.
Analyytikot asettavat tällä hetkellä Accolade-osakkeelle keskimääräisen tavoitehinnan 6,83 USD (mediaani: 7,17 USD), mikä merkitsee −2,7 % viimeisimpään hintaan verrattuna. Konsensus perustuu 18 analyytikkoarvioon.
16 analyytikkoa arvioi tällä hetkellä Accolade-osaketta: 0 suosittaa ostoa, 13 pitoa ja 3 myyntiä. Vuodelle 2026 analyytikot odottavat Accolade-yhtiöltä 521,26 M USD liikevaihtoa ja −1,01 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Accolade-osake noteerataan hintaan 6,26 EUR (7,02 USD).
Accolade-osake (ACCD) on listattuna 4 pörssissä, muun muassa: NASDAQ (ACCD), Frankfurt (4NE1.F), München (4NE1.MU), Düsseldorf (4NE1.DU).
Accolade is a technology and healthcare company that develops innovative solutions for improving healthcare.
odotettu liikevaihto Accolade on 521,26 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Accolade on −81,17 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Accolade:n hinta-voitto-suhde (P/E) on tällä hetkellä −6,97. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Accolade-osakkeen arvostusta.
Accolade:n hinta-myynti-suhde (P/S) on tällä hetkellä 1,09. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Accolade-osakkeen arvostuskennuslukuna.
Accolade:n Eulpool-laatuscore on 2/10.
Accolade:n ISIN on US00437E1029. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Accolade:n WKN on A2P7Z2. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Accolade:n ticker on ACCD. Tämä pörssinoteeraus käytetään Accolade-osakkeiden kauppaan pörssissä.
Accolade osake
Accolade vertaisryhmä
Accolade Ticker
Accolade FIGI
Kaikki tunnusluvut ja syvällinen analyysi Accolade:sta
Meidän osakeanalyysimme Accolade-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Accolade:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: